ClinicalTrials.gg
RecruitingNCT07329283N-SyncUpdated Jan 22, 2026

Nighttime Synchrony of Your Nutrition and Circadian Health

An interventional study of Central Clock Misalignment and Peripheral Misalignment in Sleep, Metabolism Changes and Circadian Rhythm, sponsored by University of Utah. Recruiting at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-22.

Sponsored by University of Utah · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Dec 2025; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Sleep is an important factor for overall health. This study will see how different light exposure patterns and food intake impact a person's metabolism (how the body breaks down food) when sleeping is reduced.

Participants will attend 6 to 8 in-person visits to the study clinic, including three overnight stays. People will complete surveys and medical tests. The study will last about 4 to 6 months.

Read the detailed description

This study is a randomized in-lab, cross-over trial. Each participant will complete all three arms in either condition order #1 (A-B-C) or order #2 (A-C-B). Each arm will consist of 5 nights of experimental sleep restriction followed by a constant routine protocol for assessment of 24-h rhythms. Sleep restriction in the three arms will occur under the following conditions: (A-control condition) Sleep Restriction with Central and Peripheral Alignment; (B) Sleep Restriction with Central Clock Misalignment; and (C) Sleep Restriction with Peripheral Misalignment. Prior to enrollment participants will complete a comprehensive medical history and clinical overnight sleep disorders screening. Baseline consists of a \~2-week ambulatory real-world monitoring segment that will occur immediately prior to each in-lab sleep restriction condition. Following the 5 days of sleep restriction in each arm, participants will complete an intravenous glucose tolerance test to analyze insulin sensitivity, prior to completing the constant routine.

02

Conditions studied

  • Sleep
  • Metabolism Changes
  • Circadian Rhythm
  • Lifestyle Factors
  • Sleep Hygiene
  • Sleep Hygiene, Inadequate
  • Sleep Deprivation
  • Insufficient Sleep
  • Circadian Misalignment
  • Circadian Dysregulation
  • Light Exposure

Keywords

  • Sleep
  • Light Exposure
  • Metabolism
  • Circadian Rhythm
  • Food Intake
  • Lifestyle Factors
  • Sleep Hygiene
03

In context

Sleep Hygiene

126 studies on the registry are indexed under Sleep Hygiene; 32 are open to participants now.

This study's planned enrollment of 120 is above the median of 66 across 113 interventional studies indexed under Sleep Hygiene.

Browse Sleep Hygiene studies →

Lead sponsor

University of Utah is the lead sponsor of 994 studies on the registry; 175 are open to participants now.

Of its 114 completed or terminated interventional studies of FDA-regulated products, 69 (61%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age: 18-35 years old; equal numbers of men and women
  2. (BMI): 18.5-24.9 kg/m2
  3. Sleep Habits: habitual self-reported average total sleep time (TST) 7-9 hours per night for prior 6 months

Exclusion criteria

Exclusion Criteria:

  1. Clinically diagnosed sleep disorder or apnea hypopnea index (AHI) ≥5
  2. Evidence of significant organ system dysfunction or disease (e.g., heart disease, diabetes)
  3. Fasting plasma glucose ≥100 mg/dL
  4. Major psychiatric illness (e.g., major depressive disorder)
  5. Cancer that has been in remission less than 5 years
  6. History of shift-work in prior year
  7. Weight change >5% of body weight over prior six months
  8. Currently following a weight-loss program
  9. Menopause
  10. Pregnant/nursing
  11. Greater than 5-day variation in menstrual cycle length month-to-month
  12. Currently smoking
  13. Alcohol intake >14 drinks/week or >3 drinks/day.
  14. Use of prescription medications (except oral ) within one month prior to or during in-lab visits.
  15. Consumption of illegal drugs or >500mg per day of caffeine.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • No intervention
    Sleep Restriction with Central and Peripheral Alignment

    (Arm "A")-Control condition with central and peripheral aligned circadian rhythms

  • Experimental
    Sleep Restriction with Central Clock Misalignment

    (Arm "B")-Misalignment of the central clock by nighttime electrical light exposure and dim-light in morning hours.

    Behavioral: Central Clock Misalignment

  • Experimental
    Sleep Restriction with Peripheral Misalignment

    (Arm "C")-Misalignment of peripheral oscillators by shifting the majority of food intake to the nighttime hours.

    Behavioral: Peripheral Misalignment

Interventions

  • BehavioralCentral Clock Misalignment

    Light exposure will be dimmed during the first 4 hours of scheduled wakefulness, with bright light exposure during the nighttime hours of extended wakefulness.

  • BehavioralPeripheral Misalignment

    Most daily calories will be given later in the day to shift eating patterns toward the nighttime hours.

06

What researchers measure

Primary outcomes

  1. Insulin Sensitivity

    Insulin sensitivity will be measured by intravenous glucose tolerance tests.

    Time frame: Immediately following the 5-day sleep restriction segment

  2. Internal Circadian Misalignment (Uridine and Isobutyryl-L-carnitine)

    Phase angle between DLMO and acrophase of uridine and isobutyryl-L-carnitine during constant routine.

    Time frame: During the constant routine, following the 5-day sleep restriction segment

Other outcomes

  1. Timing of DLMO and DLMOff

    The phase angle between dim-light melatonin offset (DLMOff) scheduled waketime using hourly saliva samples collected during a constant routine.

    Time frame: During the constant routine, following the 5-day sleep restriction segment

  2. Hunger and Satiety Visual Analog Scales

    Self-reported ratings of hunger, satiety, and prospective food intake will be quantified by 100mm visual analog scales ranging from 0 to 100. For each scale, 0 represents low hunger, satiety, or prospective food intake, with 100 representing the highest hunger, satiety, or prospective food intake.

    Time frame: During the constant routine, following the 5-day sleep restriction segment

07

Study locations

1 of 1 sites recruiting
  • College of Health Research Complex - University of Utah, Salt Lake City 84112
    Salt Lake City, Utah 84112, United States
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for May 2030, 53 months after the start.

Of 75 non-industry interventional studies with no phase under Sleep Hygiene, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 18. This study's planned 53 months is above that.

Counting every sponsor, half of 79 studies reached it within 8 months; a quarter within 4 and three quarters within 18.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2025
First posted
Jan 9, 2026
StartActual
Dec 19, 2025
Primary completionEst.
May 31, 2030
CompletionEst.
May 31, 2031
Last update
Jan 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07329283
Lead sponsor
University of Utah
Responsible party
Christopher Depner (PhD, University of Utah) — Principal investigator
First posted
Jan 9, 2026
Start date
Dec 19, 2025
Primary completion
May 31, 2030 (estimated)
Completion
May 31, 2031 (estimated)
Last update
Jan 22, 2026

Study contacts

Victoria Miranda, MS
Contact
SleepStudyParticipant@utah.edu
385-309-0551
Grace Zimmerman, PhD
Contact
SleepStudyParticipant@utah.edu
385-309-0551
Christopher Depner, PhD
principal investigator · University of Utah

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion